{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:58:10Z","timestamp":1791619090268,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010782","name":"Elsa and Gustav Lindhs Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejim.2025.106438","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T19:56:00Z","timestamp":1754942160000},"page":"106438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bleeding risk on rivaroxaban versus apixaban in older patients with venous thromboembolism: a nationwide observational register-based study"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7121-6769","authenticated-orcid":false,"given":"Maria","family":"Roupe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-6605","authenticated-orcid":false,"given":"Annika","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldina","family":"Pivodic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Bertilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Philipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-2978","authenticated-orcid":false,"given":"Kristina","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazdak","family":"Tavoly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6563-0893","authenticated-orcid":false,"given":"Katarina","family":"Glise Sandblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejim.2025.106438_bib0001","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ejim.2025.106438_bib0002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE Disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.ejim.2025.106438_bib0003","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.ejim.2025.106438_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12714","article-title":"Pulmonary embolism and deep vein thrombosis-comorbidities and temporary provoking factors in a register-based study of 1.48 million people","volume":"6","author":"Glise Sandblad","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ejim.2025.106438_bib0005","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/joim.13712","article-title":"Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based study","volume":"294","author":"Glise Sandblad","year":"2023","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.106438_bib0006","first-page":"529","article-title":"Treatment of venous thromboembolism in elderly patients in the era of direct oral anticoagulants","volume":"130","author":"Tritschler","year":"2020","journal-title":"Pol Arch Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2025.106438_bib0007","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejim.2025.106438_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2022.08.033","article-title":"Effectiveness and safety of direct oral anticoagulants among octogenarians with venous thromboembolism: an international multidatabase cohort study","volume":"136","author":"Douros","year":"2023","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ejim.2025.106438_bib0009","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jgs.16549","article-title":"DOACs versus VKAs in older adults treated for acute venous thromboembolism: systematic review and meta-analysis","volume":"68","author":"Chaudhary","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.ejim.2025.106438_bib0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jama.2022.1920","article-title":"Association of type of oral anticoagulant dispensed with adverse clinical outcomes in patients extending anticoagulation therapy beyond 90 days after hospitalization for venous thromboembolism","volume":"327","author":"Pawar","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ejim.2025.106438_bib0011","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11239-023-02926-3","article-title":"Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: a systematic review and meta-analysis of observational studies","volume":"57","author":"Fredman","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2025.106438_bib0012","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.thromres.2020.06.035","article-title":"Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism","volume":"193","author":"Trujillo-Santos","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2025.106438_bib0013","unstructured":"National Patient Register, N.b.o.H.a. Welfare, Editor. Uppdated 2024: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-patient-register\/ 2025."},{"key":"10.1016\/j.ejim.2025.106438_bib0014","unstructured":"National Prescribed Drug Register, N.b.o.H.a. Welfare, editor. Uppdated 2024: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-prescribed-drug-register\/. 2025."},{"key":"10.1016\/j.ejim.2025.106438_bib0015","unstructured":"National Cause of Death Register, N.b.o.H.a. Welfare, editor. 2024: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-cause-of-death\u2013register\/. 2025."},{"issue":"15","key":"10.1016\/j.ejim.2025.106438_bib0016","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/bloodadvances.2019000572","article-title":"Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world","volume":"3","author":"Aryal","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ejim.2025.106438_bib0017","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism : a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.106438_bib0018","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"23","key":"10.1016\/j.ejim.2025.106438_bib0019","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.2021.21222","article-title":"Association of Rivaroxaban vs Apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation","volume":"326","author":"Ray","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejim.2025.106438_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","article-title":"Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE","volume":"50","author":"Weitz","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2025.106438_bib0021","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2147\/CLEP.S177058","article-title":"Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries","volume":"10","author":"\u00d6hman","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.ejim.2025.106438_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008864","article-title":"Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study","volume":"5","author":"Abdul Sultan","year":"2015","journal-title":"BMJ Open"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525003176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525003176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:17:30Z","timestamp":1764659850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525003176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":22,"alternative-id":["S0953620525003176"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106438","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding risk on rivaroxaban versus apixaban in older patients with venous thromboembolism: a nationwide observational register-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106438"}}